表演者在口服类固醇治疗声带水肿期间对嗓音功能的自我感知
本研究对55例诊断为声带水肿并选择6天甲泼尼龙递减治疗的表演者进行前瞻性评估,比较治疗第1天与第6天EASE量表各亚量表得分。治疗后所有亚量表得分均显著下降(p<0.0001),几乎所有受试者均完成既定演出。作者强调不应在未行喉镜检查的情况下开具类固醇。
要点
- 55例表演者经6天甲泼尼龙递减治疗后,EASE各亚量表得分在第6天均显著下降(p<0.0001)。
- 几乎所有受试者均按计划完成演出,未因嗓音问题中断。
- 有演出安排及坚持嗓音热身的受试者,EASE改善更明显。
核心结论
- 受试者报告口服类固醇治疗后嗓音功能显著改善,并能够完成演出任务。
- 作者强调不应在未行喉镜检查的情况下开具类固醇;若发声困难持续、迅速复发或患者反复寻求治疗,应重复喉镜检查,因不良结局风险可能增加,持续使用类固醇可能掩盖更适合其他方式治疗的潜在慢性病变。
研究设计与样本
- 前瞻性评估55例(女34例、男21例)诊断为声带水肿并选择6天甲泼尼龙递减治疗的表演者。
- 受试者完成「唱歌易度评估」(EASE)并报告嗓音使用、治疗方案、演出义务及演出能力。
- 采用配对t检验和非参数Wilcoxon符号秩检验比较第1天与第6天结果。
主要发现
- 治疗后第6天EASE所有亚量表得分均下降:嗓音功能29.78降至20.59,病理风险指标26.60降至17.33,嗓音担忧6.10降至4.20。
- 上述差异具有统计学显著性(p<0.0001),且在安排了演出及坚持完成嗓音热身的受试者中改善更明显。
- 几乎所有受试者均完成既定演出,未中断。
临床怎么用
- 作者强调不应在未行喉镜检查的情况下开具类固醇。
- 作者指出若发声困难持续、迅速复发或患者反复寻求治疗,应重复喉镜检查。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Acute vocal fold edema (VFE) is often a consequence of illness, allergy, or voice overuse, causing dysphonia. Although VFE typically resolves with voice rest and treatment of predisposing causes, oral glucocorticoids are often considered for performers with imminent performance demands. There are limited data about performers' perceptions of vocal change during treatment and how this relates to their ability to perform. This study aims to examine performers' self-perceptions of vocal function with steroid treatment. METHODS: Fifty-five performers (34 F; 21 M) diagnosed with VFE who chose treatment with a 6-day methylprednisolone taper were prospectively assessed. They completed the Evaluation of the Ability to Sing Easily (EASE) and reported on their voice use, regimen, performance obligations, and ability to perform. Findings were compared between Day 1 and Day 6 using paired t-tests and nonparametric Wilcoxon signed-rank tests. RESULTS: Nearly all subjects completed scheduled performances without interruption. Following treatment, all subscales of the EASE were decreased at Day 6 (Vocal Function 29.78-20.59; Pathologic Risk Indicator 26.60-17.33; Vocal Concerns 6.10-4.20). These differences were statistically significant (p < 0.0001) and greater in subjects with performances scheduled and subjects who consistently completed vocal warmups. These findings demonstrate significant improvement in several facets of performers' self-perception of function. CONCLUSION: Subjects reported significant improvement in vocal function with oral steroid treatment and were able to meet performance obligations. It remains important that steroids are not prescribed without laryngeal examination. Examination should be repeated when dysphonia persists, recurs swiftly, or when patients seek repeated treatment, as there may be increased risk of adverse outcomes, and continued steroid use may mask underlying chronic pathology that is best treated by other means. LEVEL OF EVIDENCE: 4 Laryngoscope, 132:2434-2441, 2022.
引用
- Murphy Estes C, Chadwick K, Sadoughi B, et al. Performers' Perceptions of Vocal Function During Oral Steroid Treatment of Vocal Fold Edema. Laryngoscope. 2022. PMID: 35218020. doi:10.1002/lary.30072
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。